Editorial: diastolic dysfunction seems not to be decisive for survival after transjugular intrahepatic portosystemic stent-shunt

Aliment Pharmacol Ther. 2019 Apr;49(8):1101-1102. doi: 10.1111/apt.15221.

Authors

Christian Jansen¹, Jonel Trebicka^{2

3

4

5}

Affiliations

¹ Department of Internal Medicine I, University Clinic Bonn, Bonn, Germany.
² Department of Internal Medicine I, University Clinic Frankfurt, Frankfurt, Germany.
³ European Foundation for Study of Chronic Liver Failure, Barcelona, Spain.
⁴ Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
⁵ Institute of Bioengineering Catalunya, Barcelona, Spain.

PMID: 30920049
DOI: 10.1111/apt.15221

No abstract available

Publication types

Editorial
Comment

MeSH terms

Echocardiography
Humans
Liver Cirrhosis
Portasystemic Shunt, Transjugular Intrahepatic*
Stents